In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI

Magnetic Resonance Imaging

Volumn 15, Issue 10, 1997, Pages 1177-1186

  Liney, Gary P ^a,c   Turnbull, Lindsay W ^a   Lowry, Martin ^a   Turnbull, Lesley S ^b   Knowles, Adrian J ^a   Horsman, Anthony ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Benign prostatic hyperplasia; Magnetic resonance imaging; Magnetic resonance spectroscopy; Prostate cancer

Indexed keywords

CITRIC ACID; PROTON; WATER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSURETHRAL RESECTION;

ADENOCARCINOMA; AGED; BIOPSY; BODY WATER; CITRIC ACID; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROSTATE; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 0030721735     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(97)00182-3     Document Type: Article

References (26)

1. 1. Boring, C.C.; Squires, T.S.; Tong, T.; Montgomery, S. Cancer statistics 1994. Cancer 44:7-26; 1994.
2. 2. Kahn, T.; Burrig, K.; Schmitz-Drager; B.; Lewin, J.S.; Furst, G.; Modder, U. Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histological correlation. Radiology 173:847-851; 1989.
3. 3. Kjaer, L.; Thomsen, C.; Iversen, P.; Henriksen, O. In vivo estimation of relaxation processes in benign hyperplasia and carcinoma of the prostate by magnetic resonance imaging. Magn. Reson. Imaging 5:23-30; 1987.
4. 4. Ling, D.; Lee, J.K.T.; Heiken, J.P.; Balfe, D.M.; Glazer, H.S.; McClennan, G.L. Prostatic carcinoma and benign prostatic hyperplasia: Inability of MR imaging to distinguish between the two diseases. Radiology 158:103-107; 1986.
5. 5. Lowry, M.; Liney, G.P.; Turnbull, L.W.; Manton, D.J.; Blackband, S.J.; Horsman, A. Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy: Zonal and age-related differences. Magn. Reson. Med. 36:352-358; 1996.
6. 1H Spectroscopy of prostate pathology. In: Book of Abstracts: Society of Magnetic Resonance in Medicine, volume 1. New York: SMRM; 1993: 213.
7. 1H magnetic resonance spectroscopy and biochemical study. Magn. Reson. Med. 19:149-157; 1993.
8. 8. Kurhanewicz, J.; Vigneron, D.B.; Nelson, S.J.; Hricak, H.; MacDonald, J.M.; Konety, B.; Narayan, P. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal peripheral zone: Detection via localized proton spectroscopy. Urology 45:459-466; 1995.
9. 3) spatial resolution. Radiology 198:795-805; 1995.
10. 10. Schick, F.; Bonger, H.; Kurz, S.; Jung, W.I.; Pfeffer, M.; Lutz, O. Localized proton MR spectroscopy of citrate in vitro and of the human prostate in vivo at 1.5 T. Magn. Reson. Med. 29:38-43; 1993.
11. 11. Costello, L.C.; Franklin, R.B. Concepts of citrate production and secretion by prostate one. Metabolic relationships. The Prostate 18:25-46; 1991.
12. 12. Costello, L.C.; Franklin, R.B. Prostate epithelial cells utilize glucose and aspartate as the carbon sources for net citrate production. Prostate 15:335-342; 1989.
13. 1H spectroscopy of the human prostate: Benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma. Magn. Reson. Med. 29:285-291; 1993.
14. 31P magnetic resonance spectroscopy. J. Urol. 150:2019-2024; 1993.
15. 2 maps correlate with the citrate concentration in the prostate. NMR Biomed. 9:59-64; 1996.
16. 16. Bezzi, M.; Kressel, H.Y.; Allen, K.S.; Schiebler, M.L.; Altman, H.G.; Wein, A.J.; Pollack, H.M. Prostatic carcinoma: Staging with MR imaging at 1.5T. Radiology 169: 339-346; 1988.
17. 17. Biondetti, P.R.; Lee, J.K.T.; Ling, D.; Catalona, W.J, Clinical stage B prostate carcinoma: Staging with MR imaging. Radiology 162:325-329; 1987.
18. 18. Mulkern, R.V.; Bowers, J.L. Density matrix calculations of AB spectra from multipulse sequences: Quantum mechanics meets in vivo spectroscopy. Concepts Magn. Reson. 6:1-23; 1994.
19. 19. Barker, P.B.; Soher, B.J.; Blackband, S.J.; Chatham, J.C.; Mathews, V.P.; Bryan, R.N. Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference. NMR Biomed. 6:89-94; 1993.
20. 2 mapping: Application to the prostate. JMRI 6:603-607; 1996.
21. 21. Walsh, P.C. Benign prostatic hyperplasia. In: P.C. Walsh, R.F. Gittes, A.P. Perlmutter, T.A. Stamey, (Eds). Campbell's Urology. Philadelphia: Saunders, 1986: pp. 1248-1265.
22. 22. Kiricuta, I.O. Simplaceanu V. Cancer Res. 35:1164; 1975.
23. 23. Yacoe, M.E.; Sommer, G.; Peehl, D. In vitro proton spectroscopy of normal and abnormal prostate. Magn. Reson. Med. 19:429-438; 1991.
24. 24. Costello, L.C.; Littleton, G.K.; Franklin, R.B. Regulation of citrate-related metabolism in normal and neoplastic prostate. In Sharma, R.K.; Criss, E. (Eds.): Endocrine Control In Neoplasia. New York: Raven Press; 1978: pp. 303-314.
25. 25. Cooper, J.F.; Farid, I.J. Urol. 92:533-540; 1964.
26. 26. Marberger, H.; Marberger, E.; Lutwak-Mann, C. Br. Med. J. 1:835; 1962.